Aleph

What's the job title for a podcast-loving-hyper-organized-VC-curious-AI-enthusiast? We're calling it Aleph's Junior Creative Production Manager, and the AMP team here is looking to fill that seat 👇 (Pictured is a handful of us, in our absolutely unposed natural habitat, casually flitting about Aleph's podcast studio as we tend to do.) You can read the full job description below - worth your time if you're hungry, organized to the point of neurosis, and pumped about managing media production from research to execution. Link to apply is in the comments.

Unpopular opinion: Potential beats performance every time, says Ron Gura, Co-Founder and CEO of Empathy. "I’ll take someone hungry to learn and push boundaries over someone resting on a polished resume any day." Read about it in our newsletter, in your inbox this Wednesday. Link to subscribe in the comments.

"What’s an OKR for a board member?” Michael Eisenberg asks Noam Bardin, former CEO of Waze, on the latest episode of Invested. “The first would be, do no damage.” Noam didn’t just build Waze—he built a movement. As CEO, he redefined navigation, went head-to-head with tech giants, and scaled a community-driven platform into a global powerhouse. Then, he took on Google–loudly. Listen to the episode to hear how everything you know about community is wrong, why Noam says Google has no master plan, the biggest mistakes Waze made that set them back years, why Noam hates eggplant, and of course, what was in the letter Noam wrote that made the world "explode the next day.” Link to listen in the comments.

Nasdaq recognizes good potential when it sees it with Dream ;) Group 11 Bain Capital Ventures Tru Arrow Partners Tau Capital Aleph

Feels like just yesterday that Dream founders Shalev Hulio and Gil D. met Michael Eisenberg at the Gaza border to sign a round of funding - yet somehow we're already celebrating their $100M Series B! Led by Bain Capital Ventures, the round will help Dream continue defending nations against sophisticated state-sponsored cyber threats through AI technology. As the Dream team (sorry not sorry) said: "Here's to defending nations, protecting critical infrastructure, and building a safer digital world." Read about how in the article linked below. Congratulations Shalev Hulio, Sebastian Kurz, Gil D. and all of Dream - honored to partner with you!

Who's the better investor: George Soros or Stan Druckenmiller? Sender Cohen worked with both, and he has a hot take. Listen to the full conversation on Invested with Michael Eisenberg, linked below.

"I pay a service to make sure there's nothing about me on social media, or Google, or anything," says Sender Cohen - one of the world's best investors that you'll only hear from on this podcast. (Please don't make us take this down ;) Here's what he and Michael Eisenberg were up to in high school together, the difference between George Soros’s and Stan Druckenmiller’s investing styles (and who Sender says is the better investor), Israel’s untapped potential in alternative asset management, the world's next big investment opportunity, and much more. Latest Invested episode is out now, linked below.

He worked for the best investor in the world, has no social media (LI doesn't count), and loves a good movie quote. Meet Sender Cohen, Managing Partner at KH2 Capital and Michael Eisenberg's next guest on Invested. Episode dropping this Wednesday. Link to subscribe in the comments.

Hot take incoming from Tomer Diari: Founders need to stop focusing on software, and start focusing on services. If you know Tomer, you know he’s a big fan of Vertical SaaS - “...but it doesn't fit every market. Software is ultimately a very small piece of the global economy.” Watch Tomer’s Partner Perspective for the current state of SaaS, what companies like Lemonade and Uber did differently than everyone else 10 years ago that's still paying off today, why you should build a services company despite the naysayers, and the right way to do it. 

Unpopular opinion: AI won't cure cancer, says Dan Davidi, Founder and CEO of OHR. Read what we're all getting wrong about biotech and AI in our newsletter, coming to your inbox this Wednesday. Link to subscribe in the comments.